• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Health exclusion affects more than three in five people globally

    11/20/23 7:01:00 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $HLN alert in real time by email
    • Phase two of Economist Impact's Health Inclusivity Index, supported by Haleon, measures experience of health inclusion across 42,000 people in 40 countries



    • Health inclusivity scores fall worldwide with addition of lived experience data, exposing glaring policy-practice gap in wealthy countries



    • 66% of survey respondents experience barriers to health inclusion, with the most vulnerable worst affected



    • Index reveals stark generational divide with Gen Z and Millennials experiencing greater barriers to access and higher levels of discrimination



    LONDON, Nov. 21, 2023 (GLOBE NEWSWIRE) -- More than three in five people worldwide experience health exclusion, with vulnerable and younger populations the worst affected, according to phase two of the global Health Inclusivity Index from Economist Impact, supported by consumer health company Haleon.

    This year's study – which measures the extent and experience of health inclusion across 40 countries and 42,000 people – revealed that 66% of those surveyed face at least one barrier in accessing healthcare services. Lack of available appointments; inconvenient hours; distance and cost of travel; and lack of trust in healthcare services were the most widely reported barriers. Alarmingly, the Index also revealed that one in five people worldwide (20%) lack access to mental health services in their community, while 17% lack access to sexual health services.

    The study suggests that younger generations face particular issues, with almost half of Gen Z (45%) stating their quality of care has been compromised as a result of their age, health status, or other personal factors, compared with 19% of Baby Boomers. Almost a third of Gen Z (28%) and Millennials (32%) report that their pain or health conditions are not taken seriously by healthcare professionals. While almost a quarter of Gen Z (21%) and Millennials (22%) report they've been completely denied access to healthcare, compared with just 8% of Baby Boomers.

    Besides appointment hours and availability, together with distance and cost to travel, Gen Z are the most likely to cite lack of trust in healthcare providers and fear of discrimination as major obstacles when seeking healthcare services. 44% of Gen Z also cited social media as a trusted source of health information and advice – the highest proportion amongst all generations surveyed.

    The most vulnerable populations, namely people from marginalised groups and those with chronic health conditions, also report being denied access to healthcare (26%). Discrimination is a key barrier, with more than a quarter (27%) of those from marginalised groups and people with chronic health conditions experiencing this when interacting with healthcare providers.

    Sarah McDonald, VP Sustainability and Social Impact, Haleon, said: "With the Index revealing high rates of health exclusion worldwide, more action is needed to overcome the barriers, particularly for vulnerable populations. These latest findings reveal a clear gap between policy and experience, as the inclusive health ambitions of many of the world's wealthiest countries are out of step with the reality of their citizens. As we saw in phase one of the research, the Index demonstrates that empowering people and communities to take care of their health is key. A greater focus on community services, self-care and health literacy programmes can boost inclusion, bringing better everyday health within reach of more people."

    The first phase of the Index, launched in 2022, examined the presence, coverage and effectiveness of inclusive healthcare systems, policies and programmes. The research methodology for 2023's phase two study has been enhanced to include an assessment of people's experience of these inputs – by capturing insights from 42,000 people to understand their experiences of health inclusion or exclusion.

    With the addition of this lived experience data, health inclusivity scores have deteriorated under phase two of the Index across 85% of the countries surveyed. For example, the UK's score fell by 13%, falling from first to third place, behind Australia and Sweden. With all but one country scoring below 80 out of 100, it's clear that governments and policymakers have a long way to go in tackling health exclusion.

    The declining scores year-on-year expose a policy-practice gap between governments' ambitions of delivering inclusive health policies and systems and people's real-life experience of them. High income countries display the largest gaps, with an average 18-point difference between their scores on inclusive health policies and people's real-life experience, with Germany showing the greatest discrepancy. This reveals that many of the world's wealthiest nations are struggling to deliver inclusive health policies and systems effectively, with marginalised and vulnerable populations at greatest risk of exclusion.

    Jonathan Birdwell, Global Head of Policy and Insights, Economist Impact, said: "Measuring a country's ability to provide quality healthcare involves evaluating its policy but also its population's ability to use their healthcare services. That's why we are pleased to add lived-experience indicators to Economist Impact's Health Inclusivity Index. The results of this phase of the Index show that high-income countries still have a lot of improvements to make if they are to effectively turn their policy into action."

    In common with last year's findings, phase two of the Index concludes that empowering people and communities to have greater agency over their own health is a key driver of inclusion. Low-and-middle income countries outperform wealthier countries in this area due to their focus on community-based services, self-care and health literacy programmes. For example, 73% of people in low-and-middle income countries have been given advice or information on managing their health at home, compared with 65% for high-income countries.

    Consequently, low-middle income countries display an average policy-practice gap of just 3-points and are more effective at ensuring inclusion for marginalised groups, those with chronic health conditions and Gen Z. The fact that countries with less developed infrastructure, lower spending and fewer resources are more effective in delivering population-level health inclusivity in practice is a rich source of learning for both high-and lower-income countries.

    As a global leader in consumer health, Haleon will leverage this and other learnings from the Index to engage governments, policymakers and partners around the globe and work together to tackle the biggest barriers to health inclusivity.

    Under phase two of the Health Inclusivity Index, Australia achieves the highest score, followed by Sweden, UK, USA, France, Israel, Canada, South Korea, Germany, Switzerland and Thailand. The full findings of the Index can be found here: https://impact.economist.com/projects/health-inclusivity-index

    Media Contacts: 
    Haleon Media Contact:                   

    Gemma Thomas                              

    [email protected]  

    +44 (0) 7721376006 
    Economist Impact Media Contact:

    Holly Donahue

    [email protected]



    Notes to Editors:

    tbd

    About Haleon and Health Inclusivity

    Haleon's social impact goal is to empower millions of people a year to be more included in opportunities for better everyday health – with the company aiming to reach 50 million people a year by 2025. During 2022, we empowered more than 22.4 million people.

    We have identified three key barriers to health inclusivity that Haleon is well placed to help address, which are:

    • health literacy;

    • healthcare accessibility; and

    • bias & prejudice

    Examples of Haleon's efforts to break down barriers to health inclusivity include:

    Health Literacy:

    Our Caltrate calcium supplement brand in China has run several initiatives to raise awareness of the risks of osteoporosis and how to actively prevent and manage it. This includes working with Health Professionals to reach more consumers through online education, in-person outreach and bone density tests.

    Healthcare Accessibility:

    To help make our brands more accessible, we have collaborated with Microsoft on expanding the functionality of their Seeing AI app for Haleon products. Seeing AI is a free mobile app that scans the information on product labels and reads it out loud. Consumers can scan the barcode on UK and US Haleon products and hear crucial information such as name, ingredients, and usage instructions.

    Bias and Prejudice:

    The Advil Pain Equity Project is a long-term commitment to champion equitable and accessible pain relief in the United States, created by Advil and launched in partnership with Morehouse School of Medicine and BLKHLTH. The Advil Pain Equity Project's first campaign, Believe My Pain, is focused on illuminating the issue of pain inequity in Black communities.

    About Haleon

    Haleon (NYSE:HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

    For more information, please visit www.haleon.com

    About Economist Impact

    Economist Impact combines the rigour of a think-tank with the creativity of a media brand to engage a globally influential audience. We believe that evidence-based insights can open debate, broaden perspectives and catalyse progress. The services offered by Economist Impact previously existed within The Economist Group as separate entities, including EIU Thought Leadership, EIU Public Policy, Economist Events, El Studios and SignalNoise. Our track record spans 75 years across 205 countries. Along with creative storytelling, events expertise, design-thinking solutions and market-leading media products, we produce framework design, benchmarking, economic and social impact analysis, forecasting and scenario modelling, Press Release making Economist Impact's offering unique in the marketplace. Visit www.economistimpact.com for more information.

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a24060d5-eb9b-4fa1-8cbf-e5427cfaaa24



    Primary Logo

    Get the next $HLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLN

    DatePrice TargetRatingAnalyst
    1/23/2026Equal Weight → Overweight
    Barclays
    9/16/2025Overweight → Equal Weight
    Barclays
    9/10/2025Neutral → Buy
    Goldman
    5/27/2025$13.40Neutral → Outperform
    BNP Paribas Exane
    5/9/2025$11.25Equal-Weight → Overweight
    Morgan Stanley
    3/5/2025Buy → Hold
    HSBC Securities
    1/10/2025Overweight → Equal-Weight
    Morgan Stanley
    1/8/2025Outperform → Mkt Perform
    Bernstein
    More analyst ratings

    $HLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Haleon plc upgraded by Barclays

    Barclays upgraded Haleon plc from Equal Weight to Overweight

    1/23/26 8:10:24 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon plc downgraded by Barclays

    Barclays downgraded Haleon plc from Overweight to Equal Weight

    9/16/25 8:03:47 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon plc upgraded by Goldman

    Goldman upgraded Haleon plc from Neutral to Buy

    9/10/25 7:56:26 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief

    The breakthrough formula starts to repair sensitive areas of teeth after 60 seconds for substantial sensitivity relief in 3 days, delivering long-lasting relief with twice-daily brushing Key Takeaways Sensodyne unveils Clinical Repair, the brand's newest toothpaste option for sensitive teeth. Clinical Repair: Starts to repair sensitive areas of teeth after 60 seconds* for clinically proven long-lasting relief**. With twice daily brushing, Clinical Repair generates a protective layer that restrengthens with every use – protecting against sensitivity returning** Designed to target and strengthen enamel, addressing sensitivity at the source. Developed with a science-backe

    2/10/26 10:01:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    TUMS Unveils Sweepstakes and Limited-Edition Burn Ball to Help Fans "Pass the TUMS" Ahead of Football's Big Game

    Viral mega-creator Airrack joins the brand for a playful campaign featuring trick shots, social sweepstakes and heartburn relief that's passable WARREN, N.J., Jan. 6, 2026 /PRNewswire/ -- One in four Big Game watchers experience occasional heartburn from their favorite foods — and 75% of those fans are unprepared, without relief on hand*. This year, ahead of football's biggest showdown, TUMS is debuting the first-ever Burn Ball — a limited-edition, custom-designed football, specifically engineered to pass the TUMS and deliver fast-acting heartburn relief on game day! The most

    1/6/26 9:18:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Glasgow Caledonian University to Lead £2.6m UK Doctoral Training Programme to Tackle Global Oral Health Challenges

    Glasgow Caledonian University has secured £2.6 million to lead a major new UK-wide doctoral training programme to spearhead research into oral health and dental disease prevention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216404233/en/ Funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and delivered in partnership with Haleon, a consumer company focused on better everyday health, the six-year initiative will support 20 PhD students across five universities. Students will investigate some of the biggest challenges in oral health, including gum disease, and tooth decay and sensitivity, and will w

    12/16/25 8:54:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    SEC Filings

    View All

    SEC Form 6-K filed by Haleon plc

    6-K - Haleon plc (0001900304) (Filer)

    2/12/26 6:50:21 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Haleon plc

    SCHEDULE 13G/A - Haleon plc (0001900304) (Subject)

    2/10/26 11:23:20 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Haleon plc

    6-K - Haleon plc (0001900304) (Filer)

    2/2/26 1:54:38 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Leadership Updates

    Live Leadership Updates

    View All

    HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER

    LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE:HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025.  This appointment follows Franck Riot deciding to leave Haleon after six years in the business.  Carl joins Haleon from the Estée Lauder Companies Inc. where he has spent 13 years as Executive Vice President, Global Innovation and Research and Development. Carl previously spent over 20 years at P&G across Home, Health and Beauty Care.  Brian McNamara, Haleon's Chief Executive Officer commented: "I am delighted to welcome Carl to Haleon. Carl is a world-renowned leader in R&D, with significant experi

    6/24/25 8:00:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon Welcomes Joe Sta-Romana as Chief Customer Officer to Lead US Growth and Transformation

    WARREN, N.J., Dec. 2, 2024 /PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024.  In this role, Joe will lead the organization's customer strategy, driving growth and transformation in the US market. Joe brings extensive leadership experience to the role, having spent over 20 years in the FMCG sector and serving in the military. Most recently Joe led Unilever's Walmart business, overseeing the company's largest US customer. In his

    12/2/24 7:53:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Financials

    Live finance-specific insights

    View All

    Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition

    BOSTON, June 3, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased to announce that its portfolio company, Suave Brands Company, has successfully completed the acquisition of the ChapStick brand from Haleon (NYSE:HLN). This transaction also results in Haleon becoming a shareholder in Suave Brands Company. Suave Brands Company Chief Executive Officer, Daniel Alter, said, "As we continue to build Suave Brands Company as the top independent North American beauty & personal care company by combining the agility of a start-up with the power of market leading brands, the addition of Cha

    6/3/24 7:00:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Yellow Wood Partners Portfolio Company Suave Brands Company Acquires ChapStick from Haleon

    BOSTON, Jan. 25, 2024 /PRNewswire/ -- Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that its portfolio company Suave Brands Company has signed a binding offer to acquire the ChapStick brand from Haleon (NYSE:HLN), a global leader in consumer health. The transaction is intended to close in the first half of 2024 upon completion of customary closing and regulatory approvals. ChapStick invented the lip care category in the 1880s with the launch of a now-iconic lip balm that made ChapStick a household name. For more than a century, ChapStick has added products to its portfolio with innovative new i

    1/25/24 2:05:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon plc Announces Expiration and Results of Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK

    Not for release, publication or distribution, directly or indirectly, in or into any jurisdiction into which such distribution would be unlawful. This notice is for informational purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sell, any securities. The exchange offers referred to herein are being made solely pursuant to the Prospectus and related documents. The exchange offers referred to herein are not being made to holders of securities in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. LONDON, Oct. 31, 2022 /PRNewswire/ -- Haleon plc ("Haleon

    10/31/22 10:20:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Haleon plc

    SC 13G - Haleon plc (0001900304) (Subject)

    11/13/24 1:20:28 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Haleon plc

    SC 13D/A - Haleon plc (0001900304) (Subject)

    10/3/24 6:59:16 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Haleon plc

    SC 13D/A - Haleon plc (0001900304) (Subject)

    10/1/24 7:38:46 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary